Description

Tirzepatide 5mg

Tirzepatide 5mg is a low-dose, research-grade dual incretin peptide formulated for laboratory and scientific research applications. Widely discussed in scientific literature for its interaction with both GIP and GLP-1 receptor pathways, this concentration is ideal for pilot studies, assay validation, and early-stage metabolic research. Supplied strictly for research use only (RUO).

Key Features

• 5mg low-dose research vial

• Dual GIP & GLP-1 receptor research focus

• Lyophilized powder for improved stability

• Ideal for small-scale, screening, and exploratory research

• Batch-tested for purity and consistency

Research Uses

Tirzepatide is commonly studied in laboratory research involving:

• Dual incretin receptor signaling analysis

• Metabolic and endocrine pathway research

• Glucose regulation and insulin signaling models

• Energy balance and appetite-related investigations

 Disclaimer: This product is intended exclusively for laboratory research purposes only. Not approved for human or veterinary use.

Home Page

Product Specifications

• Product Name: Tirzepatide

• Strength: 5mg

• Form: Lyophilized powder

• Grade: Research Use Only (RUO)

• Storage: Store in a cool, dry environment; refrigerate after reconstitution according to laboratory standards

USA Shipping & Availability

• Fast and reliable USA domestic shipping

• Secure, professional laboratory-grade packaging

• Available to qualified research laboratories and institutions across the United States

Advantages and Disadvantages

Advantages

• Ideal for precision and early-phase research studies

• Supports dual GIP and GLP-1 pathway investigations

• High purity and consistency trusted by USA researchers

Disadvantages

• Not approved for clinical, diagnostic, or therapeutic use

• Requires proper laboratory handling and controlled storage